VOR 241220 7.50P (VOR241220P7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

VOR241220P7500

Watchlist

0.00
0.000.00%

15min DelayTrading Dec 11 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Vor Biopharma Price Target Maintained With a $12.00/Share by JMP Securities
Dow JonesDec 10 11:51 ET · Ratings
Oppenheimer Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $8
Moomoo NewsDec 9 16:31 ET · Ratings
Vor Biopharma Reports Promising Phase 1/2 Study Results
TipRanksDec 9 08:11 ET
Stifel Nicolaus Remains a Buy on Vor Biopharma (VOR)
TipRanksDec 9 07:57 ET · Ratings
Vor Bio Reports Promising Clinical Data for Trem-cel + Mylotarg in Acute Myeloid Leukemia Patients Post-Transplant
Quiver QuantitativeDec 9 07:41 ET
Vor Bio Presents Data on AML Therapy at ASH 2024 Annual Meeting
BenzingaDec 9 07:33 ET

Comments

Jaguar8

Dec 9 06:37

NEWS

$Vor Biopharma (VOR.US)$
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
...

Trytosaveabit

Dec 9 06:31

Update

$Vor Biopharma (VOR.US)$ Reuters· 1 min ago
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback From FDA Regarding Registrational Trial Design

1025848357

Sep 18 03:47

$Vor Biopharma (VOR.US)$ 2.8 ////

102407748

Sep 13 09:46

$Vor Biopharma (VOR.US)$ up up up

102407748

Sep 10 10:11

$Vor Biopharma (VOR.US)$